1. Home
  2. BVS vs HPI Comparison

BVS vs HPI Comparison

Compare BVS & HPI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BVS
  • HPI
  • Stock Information
  • Founded
  • BVS 2011
  • HPI 2002
  • Country
  • BVS United States
  • HPI United States
  • Employees
  • BVS N/A
  • HPI N/A
  • Industry
  • BVS Biotechnology: Electromedical & Electrotherapeutic Apparatus
  • HPI Trusts Except Educational Religious and Charitable
  • Sector
  • BVS Health Care
  • HPI Finance
  • Exchange
  • BVS Nasdaq
  • HPI Nasdaq
  • Market Cap
  • BVS 432.7M
  • HPI 441.7M
  • IPO Year
  • BVS 2021
  • HPI N/A
  • Fundamental
  • Price
  • BVS $7.15
  • HPI $16.74
  • Analyst Decision
  • BVS Strong Buy
  • HPI
  • Analyst Count
  • BVS 5
  • HPI 0
  • Target Price
  • BVS $14.40
  • HPI N/A
  • AVG Volume (30 Days)
  • BVS 391.4K
  • HPI 64.7K
  • Earning Date
  • BVS 11-04-2025
  • HPI 01-01-0001
  • Dividend Yield
  • BVS N/A
  • HPI 8.97%
  • EPS Growth
  • BVS N/A
  • HPI N/A
  • EPS
  • BVS 0.03
  • HPI N/A
  • Revenue
  • BVS $564,142,000.00
  • HPI N/A
  • Revenue This Year
  • BVS N/A
  • HPI N/A
  • Revenue Next Year
  • BVS $6.84
  • HPI N/A
  • P/E Ratio
  • BVS $252.78
  • HPI N/A
  • Revenue Growth
  • BVS 5.08
  • HPI N/A
  • 52 Week Low
  • BVS $5.81
  • HPI $12.85
  • 52 Week High
  • BVS $14.38
  • HPI $16.83
  • Technical
  • Relative Strength Index (RSI)
  • BVS 50.33
  • HPI 81.32
  • Support Level
  • BVS $6.98
  • HPI $15.93
  • Resistance Level
  • BVS $7.33
  • HPI $16.74
  • Average True Range (ATR)
  • BVS 0.27
  • HPI 0.14
  • MACD
  • BVS -0.04
  • HPI 0.07
  • Stochastic Oscillator
  • BVS 22.37
  • HPI 100.00

About BVS Bioventus Inc.

Bioventus Inc is a medical technology company. The company is engaged in developing and commercializing clinically differentiated treatments that engage and enhance the body's natural healing process. It offers a diverse portfolio of products to serve physicians spanning the orthopedic continuum, including sports medicine, total joint reconstruction, hand and upper extremities, foot and ankle, podiatric surgery, trauma, spine and neurosurgery. Its portfolio of products is grouped into three verticals based on clinical use: Pain Treatments, Surgical Solutions, and Restorative Therapies. Geographical presence is in the United States which derives key revenue, and International markets.

About HPI John Hancock Preferred Income Fund of Beneficial Interest

John Hancock Preferred Income Fund is a closed-end, diversified management investment company. Its primary investment objective is to provide a high level of current income consistent with preservation of capital. The fund's secondary investment objective is to provide growth of capital to the extent consistent with its primary investment objective. It seeks to achieve its investment objectives by investing in securities that may be undervalued relative to similar securities in the marketplace. The fund's principal investment strategies include investing a majority of its assets in preferred stocks and other preferred securities. Its portfolio composition consists of U.S preferred securities, common stocks, foreign preferred securities, corporate bonds, and short-term investments.

Share on Social Networks: